Phibro Animal Health (PAHC) Q1 FY2024 earnings: revenue $231 million, down 0.5% on the year

Phibro Animal Health Corp. (PAHC) reported revenue of $231 million for Q1 FY2024, the quarter ended 30 September 2023, down 0.5% on the same quarter a year earlier. Net income was -$8 million, and diluted earnings per share $-0.20. The figures are the company's own, from the 10-Q it filed with the SEC on 8 November 2023.

Revenue$231 milliondown 0.5%

Net income-$8 million

Diluted EPS$-0.20

QuarterQ1 FY2024ended 30 September 2023

The quarter, against the one before and a year earlier

Line	Q1 FY2024	Quarter before	A year earlier	Change on the year
Revenue	231	n/a	n/a	n/a
Cost of revenue	164	n/a	n/a	n/a
Gross profit	67.7	n/a	n/a	n/a
Gross margin	29.3%	n/a	n/a
Selling, general and administrative	68.5	n/a	n/a	n/a
Operating income	-0.7	n/a	n/a	n/a
Operating margin	-0.3%	n/a	n/a
Interest expense	5.6	n/a	n/a	n/a
Pre-tax income	-12.0	n/a	n/a	n/a
Income tax	-4.0	n/a	n/a	n/a
Net income	-8.0	n/a	n/a	n/a
Net margin	-3.5%	n/a	n/a
Diluted EPS	-$0.20	n/a	n/a	n/a

$ million except per share.

Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow and capital returned

Line	Q1 FY2024	Quarter before	A year earlier	Change on the year
Operating cash flow	16.2	n/a	n/a	n/a
Capital expenditure	7.5	n/a	n/a	n/a
Free cash flow	8.7	n/a	n/a	n/a
Free cash flow margin	3.8%	n/a	n/a
Cash from investing	-15.4	n/a	n/a	n/a
Cash from financing	1.3	n/a	n/a	n/a
Depreciation and amortisation	8.9	n/a	n/a	n/a
Share-based compensation	0.1	n/a	n/a	n/a
Dividends paid	4.9	n/a	n/a	n/a
Dividend per share	$0.12	n/a	n/a	n/a
Diluted shares, weighted	41m	n/a	n/a	n/a

Cash flow lines for the quarter; where the company files them year to date, the quarter is the difference between two filings.

Balance sheet at quarter end

Line	Q1 FY2024	Quarter before	A year earlier	Change on the year
Shareholders' equity	273	n/a	n/a	n/a
Debt	329	n/a	n/a	n/a
Operating lease liabilities	29.0	n/a	n/a	n/a
Other liabilities	334	n/a	n/a	n/a
Total liabilities and equity	965	n/a	n/a	n/a
Fixed assets	193	n/a	n/a	n/a
Goodwill	53.3	n/a	n/a	n/a
Intangible assets	52.2	n/a	n/a	n/a
Investments	48.0	n/a	n/a	n/a
Cash and equivalents	43.2	n/a	n/a	n/a
Receivables	149	n/a	n/a	n/a
Inventory	279	n/a	n/a	n/a
Other assets	146	n/a	n/a	n/a
Total assets	965	n/a	n/a	n/a

Questions

What was Phibro Animal Health's revenue in Q1 FY2024?

Phibro Animal Health (PAHC) reported revenue of $231 million for Q1 FY2024, the quarter ended 30 September 2023, down 0.5% on the same quarter a year earlier.

How much did Phibro Animal Health earn in Q1 FY2024?

Net loss for Q1 FY2024 was $8 million, and the diluted loss per share $0.20.

When did Phibro Animal Health report Q1 FY2024 results?

Phibro Animal Health filed its 10-Q for the quarter ended 30 September 2023 with the SEC on 8 November 2023.

Quarterly results, the last 12 quarters

	Q1 FY2024	Q2 FY2024	Q3 FY2024	Q4 FY2024 *	Q1 FY2025	Q2 FY2025	Q3 FY2025	Q4 FY2025 *	Q1 FY2026	Q2 FY2026	Q3 FY2026	Q4 FY2026 *
Revenue	231	250	263	273	260	309	348	379	364	374	384	397
Cost of revenue	164	171	184	186	177	207	243	269	244	241	258	262
Gross profit	67.7	78.6	79.6	87.2	83.5	102	105	110	120	133	126	134
Gross margin	29%	31%	30%	32%	32%	33%	30%	29%	33%	35%	33%	34%
SG&A	68.5	62.9	59.7	68.7	65.8	76.3	71.1	76.3	68.5	82.3	81.0	86.2
Operating income	-0.7	15.7	19.9	18.4	17.7	25.5	33.5	33.7	51.3	50.3	44.7	48.2
Operating margin	-0%	6%	8%	7%	7%	8%	10%	9%	14%	13%	12%	12%
Interest expense	5.6	5.7	5.6	6.0	8.8	9.8	9.7	9.0	12.5	12.5	10.7	10.7
Pre-tax income	-12.0	3.6	12.9	6.4	9.6	4.8	29.7	23.8	36.3	36.4	32.3	32.3
Tax rate	n/a	64%	35%	88%	27%	34%	30%	28%	27%	25%	26%	33%
Net income	-8.0	1.3	8.4	0.8	7.0	3.2	20.9	17.2	26.5	27.5	24.0	21.7
Net margin	-3%	1%	3%	0%	3%	1%	6%	5%	7%	7%	6%	5%
Diluted EPS	-$0.20	$0.03	$0.21	$0.02	$0.17	$0.08	$0.51	$0.43	$0.65	$0.67	$0.59	$0.52
Operating cash flow	16.2	31.6	11.4	28.4	12.6	3.1	43.2	21.3	9.3	19.4	16.2	24.1
Capital expenditure	7.5	11.0	9.7	13.1	9.6	7.8	7.7	13.1	13.8	11.1	15.3	18.9
Free cash flow	8.7	20.6	1.7	15.4	3.0	-4.7	35.4	8.1	-4.5	8.3	0.9	5.2
Dividends paid	4.9	4.9	4.9	4.9	4.9	4.9	4.9	4.9	4.9	4.9	4.9	4.9
Filing	10-Q	10-Q	10-Q	10-K	10-Q	10-Q	10-Q	10-K	10-Q	10-Q	10-Q	10-K

Each quarter as filed, linked to its filing.

* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.

Source

10-Q for the period ended 30 September 2023, filed 8 November 2023, accession 0001558370-23-018287: the filing on EDGAR. All of Phibro Animal Health Corp.'s filings: EDGAR company page.

The same record on your computer

GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.

Install